Company Filing History:
Years Active: 2021-2024
Title: The Innovations of Jeffrey R. Finkelmeier: Advancements in Cardiac Monitoring
Introduction
Jeffrey R. Finkelmeier, based in Collegeville, PA, is an innovative inventor recognized for his contributions to cardiac telemetry. With two patents to his name, Finkelmeier has developed methods that enhance the way ECG data is processed and presented, improving patient monitoring and care.
Latest Patents
Finkelmeier's latest patent, titled "End of Service Summary Report for Mobile Cardiac Outpatient Telemetry," introduces a novel method for filtering ECG data. This patent details a process of receiving and generating an ECG report that comprises multiple pages, with priority information prominently displayed on the first page. This crucial information includes patient identification, monitoring summary details such as the total duration of monitoring, average heart rate, as well as a count of different types of cardiac arrhythmias. Notably, the first page of the report is designed to be succinct, omitting ECG strips, thereby streamlining the information for healthcare providers.
Career Highlights
Throughout his career, Finkelmeier has worked with notable companies, including Braemar Manufacturing LLC and Koninklijke Philips Corporation N.V. His experience in these organizations has equipped him with the expertise to innovate in the realm of cardiac healthcare technologies.
Collaborations
In his professional journey, Finkelmeier has collaborated with esteemed colleagues, such as Wayne Michael Derkac. These collaborations have likely contributed to the successful development of his patented technologies, enhancing the overall quality of cardiac monitoring solutions.
Conclusion
Jeffrey R. Finkelmeier exemplifies the spirit of innovation in healthcare technology. Through his advancements in mobile cardiac outpatient telemetry, he has made significant strides in the effectiveness of ECG data reporting, ultimately aiming for better patient outcomes. With a commitment to improving cardiac care, Finkelmeier stands as a key figure in the ongoing evolution of medical technology.